Future Cannabis Strategies brings together business leaders from across the wider European Consumer-Facing Cannabis products category for 2 days of insight, discussion and debate into how cannabis product manufacturers can understand:
Tired of politicians dodging the debate on the legalization and normalization of cannabis in all its forms – from recreational and medical to the embrace of hemp as an alternative to manmade materials that harm the planet? Then perhaps it’s time for a Citizens’ Assembly…
The purpose of this case report is to describe a patient with a preoperative complex pain syndrome who underwent liver transplantation and was able to reduce his opioid consumption significantly following the initiation of treatment with medical cannabis. Reductions in opioid consumption were achieved with the administration of medical cannabis in a patient with acute postoperative pain superimposed on a chronic pain syndrome and receiving high doses of opioids. Concurrent benefits of initiating medical cannabis may include improvements in pain profile and functional status along with reductions in opioid-related side effects. This highlights the potential for medical cannabis as an adjunct medication for weaning patients from opioid use.
